Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Kestra Medical Technologies (KMTS) EBT Margin (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed EBT Margin for 2 consecutive years, with 145.14% as the latest value for Q4 2025.

  • On a quarterly basis, EBT Margin fell 501.0% to 145.14% in Q4 2025 year-over-year; TTM through Oct 2025 was 165.68%, a 1916.0% increase, with the full-year FY2025 number at 176.24%, up 9475.0% from a year prior.
  • EBT Margin was 145.14% for Q4 2025 at Kestra Medical Technologies, down from 133.15% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 133.15% in Q3 2025 to a low of 260.93% in Q1 2024.